Search Results

BPGbio, Inc. today announced the application of its NAi Interrogative Biology® Platform across several drug and diagnostic applications, following successful collaborations with Stanford University, University of Tennessee, Oak Ridge National Laboratory, and several leading hospitals across Mexico.

Biosenta Inc. (CSE: ZRO) (“Biosenta” or the “Company”) announces that it has entered into an agreement with Oak Hill Financial Inc. (“Oak Hill”) to provide business

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the non-exclusive engagement of Oak Hill Asset Management Inc. (“OHAM”), an Exempt Market Dealer to provide capital markets advice related to the Company’s capital markets strategy.

Sterling Ridge Orthopaedics & Sports Medicine proudly announces a groundbreaking achievement in orthopaedic surgery with Dr. Paul Chin, MD, PhD, FAAOS, FAANA, at the forefront.

Oak Hill Bio and Chiesi announced that the first patient has been enrolled in a resumed Phase 2b clinical study to assess the efficacy and safety of OHB-607, an investigational drug candidate being developed to treat complications of extremely premature birth, including bronchopulmonary dysplasia, a serious condition for which there are no approved therapies.

Carl Zeiss Industrial Metrology, LLC has partnered with Oak Ridge National Laboratory on a project chosen to receive funding through the U.S. Department of Energy’s Technology Commercialization Fund project solicitation.

Chiesi Group and Oak Hill Bio will collaborate closely to develop OHB-607, a clinical-stage investigational drug candidate being developed to treat complications of extremely premature birth.

A collaboration between Cummins Inc. and the Carbon Fiber Technology Facility at the Department of Energy’s Oak Ridge National Laboratory has resulted in the ability to produce enough filter media to supply more than a million face masks and respirators per day to U.S. healthcare facilities.